期刊文献+

腋淋巴结阴性乳腺癌中基因表达PTEN和微血管密度的关系及意义

The Correlation between Expression of PTEN and MVD in Patients with Axillary Node Negative Breast Cancer
下载PDF
导出
摘要 目的:研究腋淋巴结阴性(ph node negative,LN N)乳腺癌中PTEN蛋白的表达,探讨与微血管密度lym(VD)及患者预后的关系。方法:应用免疫组化S-P法检测81例LN N乳腺癌及20例癌旁乳腺组织中PTEN和MCD34蛋白的表达,分析与各临床病理因素和预后的关系。结果:32.6%的患者PTEN蛋白表达减低或完全阴性表达,PTEN与乳腺癌病理分级,ER状态和复发转移显著相关;PTEN阳性表达组的5年生存率(83.7%)明显高于阴性表达组(66.7%)(P<0.05);PTEN的表达与M VD呈显著的负相关关系(r=-0.552,P<0.01)。结论:PTEN缺失是乳腺癌发生过程中的多发事件,并有抑制血管生成的作用,PTEN缺失和高M V D的LNN乳腺癌患者5年生存率低,两者的检测有助于提高评估LN N乳腺癌患者术后生存的准确性。 Objective: To investigate the expression and significance of tumor suppressor gene PTEN in axillary node negative breast cancer and to analyze the relationship between PTEN and microvessel density(MVD). Methods: Eighty-one cases of breast cancer and 20 cases of corresponding adjacent tissues were performed by immunohistochemical staining (S-P) for the expressions of PTEN and CD34, as well as MVD. Results were compared with the clinical pathologic parameters and patients' survival. Results: The positive expression rate of PTEN in breast cancers(67.4%) was significantly lower than that of adjacent tissues (95.8%). Loss of PTEN was significantly associated with tumor grade, ER status, recurrence and distant metastasis. The 5 years survival rate of PTEN positive group was significantly higher than that of PTEN negative group. PTEN expression significantly negative correlated with MVD (r=-01511, P<0101). Conclusions: Loss of PTEN protein is a common event in LNN breast cancer and may play an important role in tumor angiogenesis. Patients with negative PTEN and high MVD have a short survival. Detection for expression of PTEN and MVD is helpful to evaluate the prognosis of patients with axillary node negative breast cancer.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2005年第5期248-251,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金(编号:30300124) 高等学校博士学科点专项科研基金(编号:20020422042)资助
关键词 乳腺肿瘤 PTEN CD34 微血管密度 预后 Breast neoplasm PTEN CD34 Microvessel density Prognosis
  • 相关文献

参考文献9

  • 1Petrocelli T, Slingerland JM. PTEN deficiency: a role in mammary carcinogenesis[J]. Breast Cancer Res, 2001, 3(6): 356~360
  • 2Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors[J]. Breast Cancer Res Treat, 1995, 36(2): 169~180
  • 3Perren A, Weng LP, Boag AH, et al. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast[J]. Am J Pathol, 1999, 155(4): 1253~1260
  • 4Depowski PL, Rosenthal SI, Ross JS, et al. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer[J]. Mod Pathol, 2001, 14(7): 672~676
  • 5Weng LP, Brown JL, Eng C. PTEN coordinates G1 arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model[J]. Hum Mol Genet, 2001, 10(6): 599~604
  • 6Campbell RA, Bhat-Nakshatri P, Patel NM, et al. Phosphatidylinositol 3-Kinase/AKT-mediated activation of estrogen receptor A new model for anti-estrogen resistance [J]. J Biol Chem, 2001,276(13): 9817~9824
  • 7Hansen S, Sorensen FB, Vach W, et al. Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients [J]. Histopathology, 2004, 44(5):428 ~436
  • 8Bose S, Crane A, Hibshoosh H, et al. Reduced expression of PTEN correlates with breast cancer progression [J]. Hum path,2002, 33(4): 405~409
  • 9Jiang BH, Zheng JZ, Aoki M, et al. PI3K signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells[J]. Proc Natl Acad Sci USA, 2000, 97(4): 1749 ~1753

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部